BMI View: Côte d’Ivoire has a fast-growing economy, with an expanding consumer sector and numerous opportunities for investment. Healthcare and pharmaceuticals are no exception to this rule, offering investors access to double-digit growth potential. However, these figures are not without risks. Security concerns remain and, in the healthcare market in particular, access to medicines is limited outside of larger towns and cities, counterfeit drugs are commonplace and the supply chain infrastructure is incomplete. In the short term, Côte d’Ivoire’s pharmaceutical market will be dominated by essential medicines, with notfor- profit organisations and corporate social responsibility programmes funding these drugs. The …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=114503.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/cote-divoire-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.
No comments:
Post a Comment